AAPM, ACR release statement on radioactive material in cremated bodies

The American Association of Physicists in Medicine (AAPM) and American College of Radiology (ACR) have published a statement to ease potential concerns from the general public about radioactive material in cremated bodies.

The statement is related to a recent research letter published by JAMA. The letter’s authors observed that radiation contamination was present at a crematorium where a patient who had been treated with a radiopharmaceutical had been cremated.

“Radioactive materials are used routinely in medical practice to improve human health,” according to the AAPM/ACR statement. “The risk of harm to the crematorium operator is so small that it cannot be measured.”

The statement also notes that consensus guidelines from the Centers for Disease Control and Prevention and Department of Energy address this subject in great detail.

“The low-cost best practice of installing a simple radiation detector in hospital morgues, funeral homes and crematoriums would quickly alert staff to the presence of radioactivity,” according to the statement. “A certified medical physicist or health physicist has the expertise to determine when the measured radiation levels will have decreased to a level where it is safe to release the body to coroners, medical examiners, or mortuary services.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.